Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

5.25
Delayed Data
As of Aug 26
 -0.13 / -2.42%
Today’s Change
4.15
Today|||52-Week Range
9.96
-34.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues1.9M2.5M2.1M2.3M
 
 
 
 
 
Cost of Goods Sold994.9K1.4M2.4M1.2M
 
 
 
 
 
Depreciation And Amortization117.9K117.2K118.4K116.0K
 
 
 
 
 
 
Operating ExpensesGross Income739.6K1.0M-423.0K927.5K
 
 
 
 
 
General Expenses5.4M5.1M3.7M6.4M
 
 
 
 
 
Research And Development2.1M2.0M2.0M3.4M
 
 
 
 
 
Total Operating Expenses6.5M6.6M6.3M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-4.1M-4.2M-5.5M
 
 
 
 
 
Interest Expense On Debt449.3K463.9K467.4K538.0K
 
 
 
 
 
Other Expenses0.000.000.004.5K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-4.6M-4.6M-6.0M
 
 
 
 
 
Net Income-5.1M-4.6M-4.6M-6.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M10.7M10.7M12.1M
 
 
 
 
 
Shares To Calculate EPS Diluted10.7M10.7M10.7M12.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.43-$0.43-$0.50
 
 
 
 
 
EPS Diluted-$0.48-$0.43-$0.43-$0.50